Literature DB >> 15754741

Turner syndrome and GH treatment: the state of the art.

A M Pasquino1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15754741     DOI： 10.1007/BF03345312

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  37 in total

1.  Does growth-hormone supplementation affect adult height in Turner's syndrome?

Authors:  S P Taback; R Collu; C L Deal; H J Guyda; S Salisbury; H J Dean; G Van Vliet
Journal:  Lancet       Date:  1996-07-06       Impact factor: 79.321

2.  Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.

Authors:  E Cacciari; L Mazzanti
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

3.  SHOX mutations in dyschondrosteosis (Leri-Weill syndrome).

Authors:  V Belin; V Cusin; G Viot; D Girlich; A Toutain; A Moncla; M Vekemans; M Le Merrer; A Munnich; V Cormier-Daire
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

4.  Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group.

Authors:  S D Chernausek; K M Attie; J F Cara; R G Rosenfeld; J Frane
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

5.  Final height in Turner syndrome patients treated with growth hormone.

Authors:  P Rochiccioli; J Battin; A M Bertrand; M Bost; S Cabrol; Y le Bouc; J L Chaussain; P Chatelain; M Colle; P Czernichow
Journal:  Horm Res       Date:  1995

6.  Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.

Authors:  Charmian A Quigley; Brenda J Crowe; D Greg Anglin; John J Chipman
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

7.  Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height.

Authors:  G Haeusler; K Schmitt; P Blümel; E Plöchl; T Waldhör; H Frisch
Journal:  Acta Paediatr       Date:  1996-12       Impact factor: 2.299

8.  Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.

Authors:  G Massa; C Heinrichs; S Verlinde; M Thomas; J P Bourguignon; M Craen; I François; M Du Caju; M Maes; J De Schepper
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

9.  Final height after long-term growth hormone treatment in Turner syndrome. European Study Group.

Authors:  J Van den Broeck; G G Massa; A Attanasio; A Matranga; J L Chaussain; D A Price; D Aarskog; J M Wit
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

10.  Treatment with two growth hormone regimens in girls with Turner syndrome: final height results. Dutch Growth Hormone Working Group.

Authors:  G Massa; B J Otten; S M de Muinck Keizer-Schrama; H A Delemarre-van de Waal; M Jansen; T Vulsma; W Oostdijk; J J Waelkens; J M Wit
Journal:  Horm Res       Date:  1995
View more
  1 in total

Review 1.  New issues in the diagnosis and management of Turner syndrome.

Authors:  Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.